Delivery across the UAE: Dubai · Abu Dhabi · Sharjah · Ajman · Ras Al Khaimah · Umm Al Quwain · Fujairah

TESAMORELIN

PERFORMANCE / SINGLE

TESAMORELIN

10MG · 20MG
Important medical and research notice

This content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.

Research Overview

A synthetic GHRH analogue studied for stimulating pulsatile pituitary GH release and downstream IGF-1 elevation.

Available Strengths

  • 10MG (TSM10-PEN)
  • 20MG (TSM20-PEN)

Research Protocol

Reference titration schedule

PeriodDoseU-100 unitsVolume
Week 11 mg300.3 mL
Weeks 2+2 mg600.6 mL

Reconstitution

Water volume3 mLConcentration3.33 mg/mLAdministrationSubcutaneousFrequencyOnce dailyCycle length12–26 weeks in the reference protocol, extendable to 52 weeks under supervision.

≈3.33 mg/mL once reconstituted

  1. Draw 3.0 mL of bacteriostatic water per 10 mg vial.
  2. Inject slowly along the vial wall; swirl gently until dissolved.

Research context

Binds pituitary GHRH receptors, prompting pulsatile growth-hormone secretion studied in lipolysis and protein-synthesis research.

Storage

2–8°C. 2–8°C with bacteriostatic water, use within 7 days; use immediately if prepared with sterile (non-bacteriostatic) water.

Research Notes

  • For educational and research reference only. Not medical advice and not intended for unsupervised human use.

References

Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source